Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of Managed Care Pharmacy : JMCP
|
November 23, 2005
Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data
Jay Margolis, John J Barron, W Daniel Grochulski
Clinical Drug Investigation
|
May 26, 2007
Quality of care and attributable healthcare costs in diabetic hypertensive patients initiated on calcium antagonist therapy
John J Barron, Ibrahim Al-Zakwani, Thomas Iarocci
The Oncologist
|
August 18, 2009
HER2 testing and subsequent trastuzumab treatment for breast cancer in a managed care environment
John J Barron, Mark J Cziraky, Thomas Weisman, et al.
Breast Cancer Research and Treatment
|
August 4, 2007
Assessing the economic burden of breast cancer in a US managed care population
John J Barron, Ralph Quimbo, Prashant T Nikam, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 22, 2007
Proton pump inhibitor utilization patterns in infants
John J Barron, Hiangkiat Tan, James Spalding, et al.
Journal of Breast Imaging
|
February 28, 2024
The Association Between Mammography Screening Frequency and Breast Cancer Treatment and Outcomes: A Retrospective Cohort Study
Ying Liu, Aliza S Gordon, Michael Eleff, et al.
Plos One
|
March 29, 2018
Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
Blake Charlton, Gboyega Adeboyeje, John J Barron, et al.
JCO Oncology Practice
|
March 11, 2020
Use of Optimal Evidence-Based Anticancer Drug Regimens in Physician Offices Versus Hospital Outpatient Facilities
Ezra Fishman, Michael J Fisch, Ying Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 22, 2022
Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
Krishna S Gunturu, Timothy T Pham, Sonali Shambhu, et al.
The American Journal of Managed Care
|
September 27, 2012
Impact of medical homes on quality, healthcare utilization, and costs
Andrea DeVries, Chia-Hsuan Winnie Li, Gayathri Sridhar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of Managed Care Pharmacy : JMCP
|
November 23, 2005
Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data
Jay Margolis, John J Barron, W Daniel Grochulski
Clinical Drug Investigation
|
May 26, 2007
Quality of care and attributable healthcare costs in diabetic hypertensive patients initiated on calcium antagonist therapy
John J Barron, Ibrahim Al-Zakwani, Thomas Iarocci
The Oncologist
|
August 18, 2009
HER2 testing and subsequent trastuzumab treatment for breast cancer in a managed care environment
John J Barron, Mark J Cziraky, Thomas Weisman, et al.
Breast Cancer Research and Treatment
|
August 4, 2007
Assessing the economic burden of breast cancer in a US managed care population
John J Barron, Ralph Quimbo, Prashant T Nikam, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 22, 2007
Proton pump inhibitor utilization patterns in infants
John J Barron, Hiangkiat Tan, James Spalding, et al.
Journal of Breast Imaging
|
February 28, 2024
The Association Between Mammography Screening Frequency and Breast Cancer Treatment and Outcomes: A Retrospective Cohort Study
Ying Liu, Aliza S Gordon, Michael Eleff, et al.
Plos One
|
March 29, 2018
Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
Blake Charlton, Gboyega Adeboyeje, John J Barron, et al.
JCO Oncology Practice
|
March 11, 2020
Use of Optimal Evidence-Based Anticancer Drug Regimens in Physician Offices Versus Hospital Outpatient Facilities
Ezra Fishman, Michael J Fisch, Ying Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 22, 2022
Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
Krishna S Gunturu, Timothy T Pham, Sonali Shambhu, et al.
The American Journal of Managed Care
|
September 27, 2012
Impact of medical homes on quality, healthcare utilization, and costs
Andrea DeVries, Chia-Hsuan Winnie Li, Gayathri Sridhar, et al.
Page
of 2